Trevi Therapeutics
TRVI
#6350
Rank
S$0.78 B
Marketcap
$8.14
Share price
-2.73%
Change (1 day)
94.11%
Change (1 year)

Trevi Therapeutics (TRVI) - Cash on Hand

Cash on Hand as of December 2024 : S$0.14 Billion

According to Trevi Therapeutics's latest financial reports the company has S$0.14 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Trevi Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.14 B33.5%
2023-12-31S$0.10 B-32.17%
2022-12-31S$0.16 B224.47%
2021-12-31S$49.79 M-16.37%
2020-12-31S$59.53 M-22.95%
2019-12-31S$77.26 M685.33%
2018-12-31S$9.83 M-66.59%
2017-12-31S$29.45 M